Monitoring therapeutic response

Monitor therapeutic response Clinical assessment Laboratory tests... 

Monitoring See Warnings. Perform periodic fasting blood glucose and HbAic measurements to monitor therapeutic response. Liver enzyme monitoring is recommended prior to initiation of therapy in all patients and periodically thereafter. Type 1 diabetes Pioglitazone and rosiglitazone are active only in the presence of... 

ST JOHN S WORT CORTICOSTEROIDS 1 plasma concentrations of corticosteroids and risk of poor or inadequate therapeutic response, which would be undesirable if used for e.g. cerebral oedema Due to induction of the hepatic metabolism by the CYP3A4 isoenzymes Monitor therapeutic response closely -clinically, with ophthalmoscopy and radiologically - and t dose of corticosteroids for desired therapeutic effect... 

In addition to administering the drug, the nurse monitors the therapeutic response (desired response) and reports adverse reactions. In the home setting, the nurse is responsible for teaching the patient and family members the necessary information to administer drugp safely in an outpatient setting. 

If diuretic therapy is warranted, monitor for therapeutic response by assessing weight loss and improvement of fluid retention, as well as exercise tolerance and presence of fatigue. 

Monitor for therapeutic response by assessing efficacy and toxicity of the antimicrobial regimen. 

After antimicrobial therapy has been instituted, the patient must be monitored carefully for a therapeutic response. Culture and sensitivity reports from specimens collected must be reviewed. 

Use appropriate blood glucose monitoring to determine the therapeutic response and to identify the minimum effective dose for the patient. Thereafter, measure... 

Children Divide daily dosage and administer equal doses every 6 hours or at intervals according to patient needs. Closely monitor plasma levels and therapeutic response. Hospitalize patients during initial treatment and start dose titration at the... 

A therapeutic response has been observed as early as 4 weeks after starting treatment, but treatment for 12 weeks may be required in some patients before clinical benefit is noted. Give consideration to increasing the daily dose to 3 g if the clinical response after 12 weeks is inadequate. Careful monitoring is recommended for doses more than 2 g/day. 

E. Therapeutic response Follicle maturation during follitropin beta therapy is best monitored by daily ultrasonography and daily measurement of serum and/or urine estradiol levels. Ovulation may be clinically confirmed by an increase in serum progesterone as well as an elevation in basal body temperature. 

Further, it is best to start with a very low dose and titrate up slowly in a hospital setting to carefully monitor clinical response, temperature, and neurological and mental status. Using low doses will not necessarily jeopardize chances for an adequate clinical response. We found, for example, evidence for a therapeutic effect with low-dose trifluoperazine (285). This finding is consistent with the growing recognition that less may indeed be more when it comes to the dose of an antipsychotic. 

---